Item Type | Name |
Academic Article
|
Epitope landscape in breast and colorectal cancer.
|
Concept
|
Antigen Presentation
|
Concept
|
CD11b Antigen
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
Concept
|
Ki-67 Antigen
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
T-Cell Antigen Receptor Specificity
|
Concept
|
Lymphocyte Function-Associated Antigen-1
|
Concept
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor
|
Concept
|
Antigen-Antibody Complex
|
Concept
|
Antigen-Antibody Reactions
|
Concept
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
|
Concept
|
Macrophage-1 Antigen
|
Concept
|
Antigen-Presenting Cells
|
Concept
|
Gene Rearrangement, delta-Chain T-Cell Antigen Receptor
|
Concept
|
B7-1 Antigen
|
Concept
|
Prostate-Specific Antigen
|
Concept
|
B7-2 Antigen
|
Concept
|
HLA-A2 Antigen
|
Concept
|
Receptors, Antigen, T-Cell, gamma-delta
|
Academic Article
|
Murine T cells with invariant gamma delta antigen receptors: origin, repertoire, and specificity.
|
Academic Article
|
The immunobiology of T cells with invariant gamma delta antigen receptors.
|
Academic Article
|
The congenic mutant B6.C-H-2bm-1 (H-2bm-1) serological response to the T-cell receptor on EL4.
|
Academic Article
|
The mouse T cell receptor: structural heterogeneity of molecules of normal T cells defined by xenoantiserum.
|
Academic Article
|
Biosynthesis and processing of murine T-cell antigen receptor.
|
Academic Article
|
Monoclonal antibody to chicken fetal antigens on normal erythroid cells and hematopoietic-lymphoid tumor cell lines.
|
Academic Article
|
T cell receptor-triggered activation of intraepithelial lymphocytes in vitro.
|
Academic Article
|
Itk negatively regulates induction of T cell proliferation by CD28 costimulation.
|
Academic Article
|
Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice.
|
Academic Article
|
B7x: a widely expressed B7 family member that inhibits T cell activation.
|
Academic Article
|
Augmentation of T cell levels and responses induced by androgen deprivation.
|
Academic Article
|
Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.
|
Academic Article
|
Restoring function in exhausted CD8 T cells during chronic viral infection.
|
Academic Article
|
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function.
|
Academic Article
|
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.
|
Academic Article
|
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion.
|
Academic Article
|
Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage.
|
Academic Article
|
Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors.
|
Academic Article
|
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses.
|
Academic Article
|
Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance.
|
Academic Article
|
CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases.
|
Academic Article
|
Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production.
|
Academic Article
|
Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy.
|
Academic Article
|
Expression of Helios in peripherally induced Foxp3+ regulatory T cells.
|
Academic Article
|
Immune modulation in cancer with antibodies.
|
Academic Article
|
Partial amino acid sequence of HLA-A9 antigen purified with a specific xenoantiserum.
|
Academic Article
|
Expression of a fetal gamma delta T-cell receptor in adult mice triggers a non-MHC-linked form of selective depletion.
|
Academic Article
|
Introduction: gamma delta T cells--the 'other' T lymphocytes.
|
Academic Article
|
The immunobiology of gamma delta+ T cells.
|
Academic Article
|
A subset of T cell receptors associated with L3T4 molecules mediates C6VL leukemia cell binding of its cognate retrovirus.
|
Academic Article
|
Structure, function, and serology of the T-cell antigen receptor complex.
|
Academic Article
|
Distinct antigen receptor repertoires of two classes of murine epithelium-associated T cells.
|
Academic Article
|
Diminished expression of the T cell receptor on the expanded lymphocyte population in MRL/Mp-lpr/lpr mice.
|
Academic Article
|
Limited diversity of gamma delta antigen receptor genes of Thy-1+ dendritic epidermal cells.
|
Academic Article
|
Gamma delta antigen receptors of Thy-1+ dendritic epidermal cells: implications for thymic differentiation.
|
Academic Article
|
The gamma T-cell antigen receptor.
|
Academic Article
|
Delta is the Cx-gene product in the gamma/delta antigen receptor of dendritic epidermal cells.
|
Academic Article
|
CD28-B7 interactions in T-cell activation.
|
Academic Article
|
Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.
|
Academic Article
|
CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help.
|
Academic Article
|
Characterization of neutrophils and T lymphocytes associated with the murine vaginal epithelium.
|
Academic Article
|
Activation and differentiation requirements of primary T cells in vitro.
|
Academic Article
|
Phenotypic and functional analysis of positive selection in the gamma/delta T cell lineage.
|
Academic Article
|
Manipulation of costimulatory signals to enhance antitumor T-cell responses.
|
Academic Article
|
T cell-mediated elimination of B7.2 transgenic B cells.
|
Academic Article
|
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer.
|
Academic Article
|
CTLA-4: new insights into its biological function and use in tumor immunotherapy.
|
Academic Article
|
Prostate cancer: advances in immunotherapy.
|
Academic Article
|
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells.
|
Academic Article
|
B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].
|
Academic Article
|
MHC class II-independent and -dependent T cell expansion and B cell hyperactivity in vivo in mice deficient in CD152 (CTLA-4).
|
Academic Article
|
Regulated costimulation in the thymus is critical for T cell development: dysregulated CD28 costimulation can bypass the pre-TCR checkpoint.
|
Academic Article
|
The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: identification of constant and variable peptides. 1983.
|
Academic Article
|
Checkpoint blockade in cancer immunotherapy.
|
Academic Article
|
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.
|
Academic Article
|
The B7 family and cancer therapy: costimulation and coinhibition.
|
Academic Article
|
Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity.
|
Academic Article
|
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies.
|
Academic Article
|
Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.
|
Academic Article
|
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
|
Academic Article
|
TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo.
|
Academic Article
|
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.
|
Academic Article
|
Response to "Ipilimumab (Yervoy) and the TGN1412 catastrophe".
|
Academic Article
|
Aire-dependent thymic development of tumor-associated regulatory T cells.
|
Academic Article
|
Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy.
|
Academic Article
|
An immune adsorption technique for analysis of antigenic determinants reacting with HLA antisera.
|
Academic Article
|
Human DR (Ia-like) antigens: biological and molecular profile.
|
Academic Article
|
Origin of Thy-1+ dendritic epidermal cells of adult mice from fetal thymic precursors.
|
Academic Article
|
Molecular characterization of the murine T cell antigen receptor and associated structures.
|
Academic Article
|
Developmentally ordered appearance of thymocytes expressing different T-cell antigen receptors.
|
Academic Article
|
Antibodies against the T cell receptor/CD3 complex interfere with distinct intra-thymic cell-cell interactions in vivo: correlation with arrest of T cell differentiation.
|
Academic Article
|
Identification of antigen receptor-associated structures on murine T cells.
|
Academic Article
|
Limited diversity of T-cell receptor gamma-chain expression of murine Thy-1+ dendritic epidermal cells revealed by V gamma 3-specific monoclonal antibody.
|
Academic Article
|
Expression and function of the CD3-antigen receptor on murine CD4+8+ thymocytes.
|
Academic Article
|
The murine T cell antigen receptor and associated structures.
|
Academic Article
|
Immunochemical characterization of differentiation and age-related cell surface antigens expressed by chicken erythrocytes.
|
Academic Article
|
Chicken fetal and adult antigen expression on erythroleukemia cells before and after induced differentiation.
|
Academic Article
|
T-cell activation: integration of signals from the antigen receptor and costimulatory molecules.
|
Academic Article
|
The role of short homology repeats and TdT in generation of the invariant gamma delta antigen receptor repertoire in the fetal thymus.
|
Academic Article
|
Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
|
Academic Article
|
Co-stimulation in T cell responses.
|
Academic Article
|
The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor.
|
Academic Article
|
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.
|
Academic Article
|
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.
|
Academic Article
|
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.
|
Academic Article
|
Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells.
|
Academic Article
|
Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. 1982.
|
Academic Article
|
Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily.
|
Academic Article
|
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
|
Academic Article
|
CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism.
|
Academic Article
|
A genetic library screen for signaling proteins that interact with phosphorylated T cell costimulatory receptors.
|
Academic Article
|
A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer.
|
Academic Article
|
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.
|
Academic Article
|
Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability.
|
Academic Article
|
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome.
|
Academic Article
|
Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes.
|
Academic Article
|
Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections.
|
Academic Article
|
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists.
|
Academic Article
|
Inhibitors of B7-CD28 costimulation in urologic malignancies.
|
Academic Article
|
Attenuated T cell responses to a high-potency ligand in vivo.
|
Academic Article
|
Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy.
|
Academic Article
|
Strength of TCR-peptide/MHC interactions and in vivo T cell responses.
|
Academic Article
|
Tissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity.
|
Academic Article
|
Pillars article: CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. The journal of experimental medicine. 1995. 182: 459-465.
|
Academic Article
|
Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses.
|
Academic Article
|
Cutting edge: CTLA-4 on effector T cells inhibits in trans.
|
Academic Article
|
Cutting edge: chronic inflammatory liver disease in mice expressing a CD28-specific ligand.
|
Academic Article
|
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.
|
Academic Article
|
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
|
Academic Article
|
Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy.
|
Academic Article
|
Gamma delta T cells in murine epithelia: origin, repertoire, and function.
|
Academic Article
|
Regulation of T-cell receptor gamma-chain RNA expression in murine Thy-1+ dendritic epidermal cells.
|
Academic Article
|
Alpha/beta T-cell antigen receptor gene and protein expression occurs at early stages of thymocyte differentiation.
|
Academic Article
|
The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: identification of constant and variable peptides.
|
Academic Article
|
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients.
|
Academic Article
|
B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse.
|
Academic Article
|
Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
|
Academic Article
|
Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer.
|
Academic Article
|
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients.
|
Academic Article
|
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
|
Academic Article
|
T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-?1 cytokine.
|
Academic Article
|
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
|
Academic Article
|
Intrathymic differentiation of V gamma 3 T cells.
|
Academic Article
|
Gamma delta T-cell development.
|
Academic Article
|
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit.
|
Academic Article
|
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial.
|
Academic Article
|
Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patients.
|
Academic Article
|
Increased frequency of ICOS+ CD4 T cells as a pharmacodynamic biomarker for anti-CTLA-4 therapy.
|
Academic Article
|
Cytotoxic T lymphocyte antigen-4 blockade enhances antitumor immunity by stimulating melanoma-specific T-cell motility.
|
Academic Article
|
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
|
Academic Article
|
Friends not foes: CTLA-4 blockade and mTOR inhibition cooperate during CD8+ T cell priming to promote memory formation and metabolic readiness.
|
Academic Article
|
The future of immune checkpoint therapy.
|
Academic Article
|
Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer.
|
Academic Article
|
Strategies for combining immunotherapy with radiation for anticancer therapy.
|
Academic Article
|
Immune Checkpoint Blockade in Cancer Therapy: The 2015 Lasker-DeBakey Clinical Medical Research Award.
|
Academic Article
|
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.
|
Academic Article
|
The T-cell antigen receptor gamma gene
|
Academic Article
|
Biosynthesis of the murine T cell antigen receptor
|
Academic Article
|
Correlation of antigen receptor expression and surface phenotype of murine T-lymphomas
|
Academic Article
|
Molecular characterization of the murine T cell antigen receptor and associated structures
|
Academic Article
|
Effect of murine Vγ3 and Vδ1 antigen receptor transgenes on T cell development
|
Academic Article
|
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality.
|
Academic Article
|
Checkpoints.
|
Academic Article
|
A conversation with James Allison.
|
Academic Article
|
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
|
Academic Article
|
Interdependent IL-7 and IFN-? signalling in T-cell controls tumour eradication by combined a-CTLA-4+a-PD-1 therapy.
|
Academic Article
|
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
|
Academic Article
|
Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.
|
Academic Article
|
Loss of IFN-? Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.
|
Academic Article
|
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity.
|
Academic Article
|
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.
|
Academic Article
|
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer.
|
Academic Article
|
Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity.
|
Academic Article
|
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.
|
Academic Article
|
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.
|
Academic Article
|
Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade.
|
Academic Article
|
Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy.
|
Academic Article
|
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers.
|
Academic Article
|
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study.
|
Academic Article
|
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy.
|
Academic Article
|
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.
|
Academic Article
|
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.
|
Academic Article
|
Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell States.
|
Academic Article
|
TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion.
|
Concept
|
gp100 Melanoma Antigen
|
Concept
|
B7 Antigens
|
Concept
|
B7-H1 Antigen
|
Concept
|
CTLA-4 Antigen
|
Concept
|
Histocompatibility Antigen H-2D
|
Academic Article
|
Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?
|
Academic Article
|
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Response.
|
Academic Article
|
Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner.
|
Academic Article
|
Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies.
|
Academic Article
|
Dissecting the mechanisms of immune checkpoint therapy.
|
Academic Article
|
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma.
|
Academic Article
|
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer.
|
Academic Article
|
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.
|
Academic Article
|
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-na?ve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment.
|
Academic Article
|
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.
|
Academic Article
|
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma.
|
Academic Article
|
T cells specific for a-myosin drive immunotherapy-related myocarditis.
|
Academic Article
|
Immune checkpoint therapy-current perspectives and future directions.
|
Academic Article
|
The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role?
|
Academic Article
|
ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotype.
|